Page last updated: 2024-11-04

terbutaline and Serotonin Syndrome

terbutaline has been researched along with Serotonin Syndrome in 1 studies

Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.

Serotonin Syndrome: An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor.

Research Excerpts

ExcerptRelevanceReference
"Oral terbutaline was begun for hemodynamic improvement."5.56Serotonin Syndrome Following Terbutaline Administration in a Heart Transplant Patient on Multiple Inotropic Agents: A Case Report. ( Maxa, JL, 2020)
"Oral terbutaline was begun for hemodynamic improvement."1.56Serotonin Syndrome Following Terbutaline Administration in a Heart Transplant Patient on Multiple Inotropic Agents: A Case Report. ( Maxa, JL, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Maxa, JL1

Other Studies

1 other study available for terbutaline and Serotonin Syndrome

ArticleYear
Serotonin Syndrome Following Terbutaline Administration in a Heart Transplant Patient on Multiple Inotropic Agents: A Case Report.
    Transplantation proceedings, 2020, Volume: 52, Issue:9

    Topics: Cardiotonic Agents; Cyproheptadine; Drug Interactions; Female; Heart Transplantation; Humans; Middle

2020